[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

US Opioids Market Hit the USD 8 Bn Mark, Says MP Advisors in Its Report Available at MarketPublishers.com

10 Oct 2016 • by Natalie Aster

LONDON – FDA has taken a number of steps in order to stop opioid abuse as well as the reversing opioid epidemic in the U.S. in the near term. And rescheduling of Hydrocodone combinations from one class to another (namely from Class III to Class II) is one of these steps.

As of 2014, the number of death involving opioids’ prescription surpassed the 18,890 mark in the USA. This figure is 13% higher than it was in 2013.

New NCEs that target opioids receptor are currently in the pipeline that reduces abuse of opioids by its MoA. They have potential to deal with the reducing opioid abuse.

The US market for opioids has hit the USD 8 billion mark, and a 50% share of this sum belongs to extended release formulations. Growth of the market in the USA and Europe is set to be driven by ADF ER formulations as well as its generic versions.

Insightful research report “Pain Management- New Discoveries and Treatment Options in Abuse Deterrent Era” drawn up by MP Advisors offers an up-close look at novel technologies which are made use of in the formulating abuse-deterrent products. The study also delves deep into technologies being employed in enhancing patient compliances.

It casts light on emerging novel mechanisms and focuses on late stage pipeline drugs relative to the management of pain. The report covers management of pain in detail: it contains the classification of pain and details on treatment approaches, estimates sizing of this market, looks at unmet needs, limelights marketed drugs, and more.

The research study focuses on the FDA schedule for controlled substances, as well. It discusses the FDA perspective relative to abuse deterrent formulations. The research report throws light on approved formulations and concentrates on technology platforms like INTAC, EGALET, LIMITX, and more.

The study comprises the pipeline analysis of novel technologies as well as new mechanisms in the pain management domain, as well. Besides, the most recent trends and developments in this space are scrutinized in the research report.

More cutting-edge studies by MP Advisors can be found at its page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest